Agenda

February 27-March 1, 2025 | Salt Lake City, Utah

Stay Informed

Thursday February 22, 2024

  • 2:00 PM – 5:00 PM

    Meeting the Masters Fellows Symposium

    • Speaker
      • Eric PrystowskyMD
      • Gregory MichaudMD
      • Melvin ScheinmanMD
  • 5:00 PM – 5:30 PM

    Refreshment Break in Foyer

  • 5:30 PM – 6:30 PM

    Fellows Research Competition

    • Faculty
      • Sana Al-KhatibMD, MHS

Friday February 23, 2024

  • 6:30 AM – 7:30 AM

    Registration

  • 7:00 AM – 8:00 AM

    Innovation Theater Breakfast (Non-CME): Improving Patient Experience Through Early Ambulation Following Atrial Fibrillation Ablation

    • Discussant
      • Amin Al-AhmadMD
  • +
    8:10 AM – 9:25 AM

    Session 1

    • Moderator
      • Andrew KrahnMD FHRS
      • Melvin ScheinmanMD
    • 8:10 AM – 8:15 AM
      Welcome Remarks
    • 8:15 AM – 8:20 AM
      David E. Haines Memorial Address
    • 8:20 AM – 8:30 AM
      What could revolutionize AF management in the near future?
    • 8:30 AM – 8:40 AM
      Digital Health & Wearables in AF: What’s Needed to Really Disrupt
    • 8:40 AM – 8:50 AM
      When Will AI Integration Enter the New AF Guidelines?
    • 8:50 AM – 9:00 AM
      ADVENT Trial: PFA vs Thermal Ablation in paroxysmal AF
    • 9:00 AM – 9:10 AM
      Predictors of AF incidence and burden in patients with no CVD: an emphasis on early population-based interventions
    • 9:10 AM – 9:25 AM
      Open Discussion
  • 9:25 AM – 10:25 AM

    Session 2 - Roundtable: Every AF patient deserves at least a PVI

    • Discussant
      • Christian MahnkopfMD, PhD
      • Jason AndradeMD FRCPC
      • Jeanne PooleMD
      • John MandrolaMD
      • Oussama WazniMD
      • Usman Rasheed Siddiqui
    • Moderator
      • Hugh CalkinsMD
      • Johannes BrachmannMD PhD
  • 10:30 AM – 10:45 AM

    Exhibit Hall/Refreshment Break

  • +
    10:50 AM – 11:55 AM

    Session 3

    • Moderator
      • Andrea RussoMD
      • Felix HohendannerMD, PhD
    • 11:00 AM – 11:10 AM
      CASTLE-HTx: Catheter Ablation versus Medical Therapy to Treat Atrial Fibrillation in End-stage Heart Failure
    • 11:10 AM – 11:20 AM
      Pulsed Field Ablation Beyond the Pulmonary Veins: Impact on AF ablation outcomes
    • 11:20 AM – 11:30 AM
      SMURDEN: a new treatment endpoint?
    • 11:30 AM – 11:40 AM
      Atrial fibrillation burden and timing of Medical Therapy in patients with screen-detected and clinically-diagnosed AF 
    • 11:40 AM – 11:55 AM
      Open Discussion
  • 12:00 PM – 1:00 PM

    Industry-Supported Symposium Lunch - Treatment Strategies for Advanced AF: Impact on Heart Failure

    • Discussant
      • Eoin DonnellanMD
      • Michael RileyMD
    • Moderator
      • Nassir MarroucheMD
    • Speaker
      • Christian SohnsProf.
      • David De LurgioMD
  • +
    1:05 PM – 2:00 PM

    Session 4

    • Moderator
      • Amin Al-AhmadMD
      • Tina BaykanerMD, MPH
    • 1:05 PM – 1:15 PM
      Atrial high rate episodes: Should we always anticoagulate? NOAH-AFNET 6 and ATRISIA
    • 1:15 PM – 12:55 PM
      Epicardial Access in Atrial Fibrillation
    • 1:25 PM – 1:05 PM
      Customizing AF Management Based on Recognized Sex-Specific Outcome Variations
    • 1:35 PM – 1:45 PM
      Global challenges in AF treatment: what can we learn from each other?
    • 1:45 PM – 2:00 PM
      Open Discussion
  • +
    2:00 PM – 2:55 PM

    Session 5

    • Moderator
      • Ahmad Abdul KarimMD
      • Douglas PackerMD
    • 2:00 PM – 2:10 PM
      Completing the Castle Brick by Brick: Can Ablation break the HFpEF-AF Cycle?
    • 2:10 PM – 2:20 PM
      Managing Peri-Device Leaks Following Watchman Device
    • 2:20 PM – 2:30 PM
      Advantages of Devices in Detecting and Diagnosing AFIB: Examples of Practice
    • 2:30 PM – 2:40 PM
      Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials.
    • 2:40 PM – 2:55 PM
      Open Discussion
  • 3:00 PM – 3:15 PM

    Exhibit Hall/Refreshment Break

  • +
    3:20 PM – 4:15 PM

    Session 6

    • Moderator
      • Gregory MichaudMD
      • Swati RaoMD
    • 3:20 PM – 3:30 PM
      Lesion Delivery and Scar Formation in Catheter Ablation for Atrial Fibrillation - The DECAAF II Trial
    • 3:30 PM – 3:40 PM
      Redefining AF Severity Using AI
    • 3:40 PM – 3:50 PM
      Morphological and Electrical Characterization of Atrial Cardiomyopathy
    • 3:50 PM – 4:00 PM
      AF and HFrEF; pace and ablate with left bundle branch pacing
    • 4:00 PM – 4:15 PM
      Open Discussion
  • +
    4:15 PM – 5:00 PM

    Session 7

    • Moderator
      • Christian MahnkopfMD, PhD
      • Thomas DeeringMD
    • 4:15 PM – 4:25 PM
      CIRCA-DOSE: Atrial Fibrillation Progression after Cryoballoon or Radiofrequency Ablation: what are the implications?
    • 4:25 PM – 4:35 PM
      Could Gene Therapy be the Future of Afib Treatment?
    • 4:35 PM – 4:45 PM
      Future directions in Pulsed Field Ablation
    • 4:45 PM – 4:55 PM
      Insights from the Prospective Multicenter REAL-AF Registry
    • 4:55 PM – 5:00 PM
      Open Discussion
  • 5:00 PM – 5:30 PM

    Exhibit Hall/Refreshment Break

  • 5:30 PM – 6:15 PM

    Session 8 - Roundtable and Live Case Review: Recent Advances in Stroke Prevention (Non-Accredited)

    • Discussant
      • Andrea NataleMD
      • Emile DaoudMD
      • Michael RileyMD
      • Vivek ReddyMD
    • Live Case Operator
      • Boris SchmidtMD
      • Devi NairMD , FACC, FHRS
      • Julian ChunMD
    • Moderator
      • Oussama WazniMD
  • 6:15 PM – 6:35 PM

    Break

  • +
    6:45 PM – 7:40 PM

    Session 9

    • Moderator
      • John DayMD
    • 6:45 PM – 6:55 PM
      How Many Ablation Modalities Does a Center Need?
    • 6:55 PM – 7:05 PM
      Understanding patterns of compliance to remote monitoring strategies in CV studies
    • 7:05 PM – 7:15 PM
      PAC induced atrial remodelling
    • 7:15 PM – 7:25 PM
      What it takes to move AF ablation practice to the outpatient setting
    • 7:25 PM – 7:40 PM
      Open Discussion

Saturday February 24, 2024

  • 6:30 AM – 7:30 AM

    Registration

  • 7:00 AM – 8:00 AM

    Innovation Theater Breakfast (Non-Accredited): Implementing Volta AI Based Dispersion EGM Guided Strategies for the Complex Substrate Patient Population

    • Discussant
      • Devi NairMD , FACC, FHRS
      • Paul Zei
    • Moderator
      • Andrea NataleMD
  • +
    8:10 AM – 9:15 AM

    Session 10

    • Moderator
      • Kamala TamirisaMD
      • Melanie GunawardeneMD
    • 8:10 AM – 8:20 AM
      Complications of Pulsed Field Ablation: lessons learned from the multi-centre EU-PORIA registry
    • 8:20 AM – 8:30 AM
      The future of LAA closure: Exploring The Latest Innovations
    • 8:30 AM – 8:40 AM
      Neuromodulation in AF therapy: Current use and future perspectives
    • 8:40 AM – 8:50 AM
      Anticoagulation in subclinical AF: The ARTESIA trial
    • 8:50 AM – 9:00 AM
      Atrial fibrillation in pregnancy
    • 9:00 AM – 9:15 AM
      Open Discussion
  • 9:15 AM – 9:40 AM

    Session 11 - Roundtable: Time to implement advanced imaging for optimized anticoagulation strategies in AF

    • Discussant
      • Edip GurolMD, MSc
      • Elaine HylekMD MPH
      • Gaston VergaraMD
      • Jason AndradeMD FRCPC
      • Stavros StavrakisMD, PhD
    • Moderator
      • Fred KusumotoMD
      • Jeff HealeyMD
  • +
    9:40 AM – 10:45 AM

    Session 12

    • Moderator
      • Boris SchmidtMD
      • Jodie Hurwitz
    • 9:40 AM – 9:50 AM
      Atrial ablation with stable, contiguous and sphere-by-sphere PFA applications
    • 9:50 AM – 10:00 AM
      Semaglutide in atrial fibrillation
    • 10:00 AM – 10:10 AM
      Optimizing Patient Selection for Combined Left Atrial Appendage Closure & AF Ablation
    • 10:10 AM – 10:20 AM
      Phenotypes in diastolic dysfunction: Is Cardiac Imaging Enough?
    • 10:20 AM – 10:30 AM
      15 years of MRI fibrosis imaging: Why is it not scalable yet?
    • 10:30 AM – 10:45 AM
      Open Discussion
  • 10:50 AM – 11:05 AM

    Exhibit Hall/Refreshment Break

  • 11:10 AM – 11:45 AM

    Session 13 - Roundtable: The hype around AI: Are we over-optimistic about the future of AI

    • Discussant
      • Chan Ho Lim
      • Felix HohendannerMD, PhD
      • Hamid GhanbariMD
      • Jorge RomeroMD
    • Moderator
      • John MandrolaMD
      • Kenneth EllenbogenMD
  • +
    11:45 AM – 12:50 PM

    Session 14

    • Moderator
      • Kevin MakatiMD
      • Narendra KanuruMD
    • 11:45 AM – 11:55 AM
      Rhythm control as early as possible: but what does "early" really mean?
    • 11:55 AM – 12:05 PM
      Is atrial myopathy a reversible process?
    • 12:05 PM – 12:15 PM
      Utilizing Big Data to improve ablation outcomes: MIRA Study
    • 12:15 PM – 12:25 PM
      Potential role of device-based electrical therapies in AF with HF
    • 12:25 PM – 12:35 PM
      Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures
    • 12:35 PM – 12:50 PM
      Open Discussion
  • 1:00 PM – 2:00 PM

    Innovation Theater Lunch (non-CME): QDOT MICRO™ Catheter Early Experience & Best Practice Sharing with Key Opinion Leaders

    • Discussant
      • Amin Al-AhmadMD
      • Andrea NataleMD
      • Nassir MarroucheMD
  • +
    2:10 PM – 3:15 PM

    Session 15

    • Moderator
      • Bassam WannaMD
      • Hamid GhanbariMD
    • 2:10 PM – 2:20 PM
      Utilizing Digital Biomarkers for Predicting and Understanding Atrial Myopathy
    • 2:20 PM – 2:30 PM
      Efficacy and safety of combined pulsed field and thermal ablations
    • 2:30 PM – 2:40 PM
      The New AF Guidelines
    • 2:40 PM – 2:50 PM
      Enhancing Ablation Outcomes: A Comprehensive Update on Left Atrial Ablation
    • 2:50 PM – 3:05 PM
      Open Discussion
  • +
    3:05 PM – 4:00 PM

    Session 16

    • Moderator
      • Gaston VergaraMD
      • Moussa MansourMD
    • 3:05 PM – 3:15 PM
      Utilizing PPG in Managing AF: Tools and AI
    • 3:15 PM – 3:25 PM
      Time to Say Goodbye to ESUS and Atrial Cardiopathy Constructs: New RCT Data, Same Negative Results
    • 3:25 PM – 3:35 PM
      LAAO vs. OAC: Which Option is Gaining the Upper Hand in Recent Data?
    • 3:35 PM – 3:45 PM
      Multimodality AI: Examples of Implementation in AF
    • 3:45 PM – 4:00 PM
      Open Discussion
  • 4:00 PM – 4:35 PM

    Session 17 - Roundtable: Meet the presidents: How presidents of societies influence the management of AF

    • Discussant
      • Ali Oto
      • Andrea RussoMD
      • Christine AlbertMD
      • Fred KusumotoMD
      • Jodie Hurwitz
      • Kenneth EllenbogenMD
      • Patricia BlakeFASAE,CAE
      • Sana Al-KhatibMD, MHS
      • Thomas DeeringMD
    • Moderator
      • Douglas PackerMD
  • 4:40 PM – 4:55 PM

    Refreshment Break

  • 5:00 PM – 6:00 PM

    Session 18 - Roundtable: Managing the risk of bleeding in my AF patient

    • Discussant
      • Bassam WannaMD
      • Jill Schaeffer
      • Mohamed Elshazly
      • Monique Mones Young
      • Will Cho
    • Moderator
      • Brent WilsonMD, PhD
      • Christopher McGannMD
  • 6:00 PM – 6:40 PM

    Session 19 - ROUNDTABLE: #ASKWAF

    • Discussant
      • Jared Bunch
      • Jill Schaeffer
      • Leslie LiMD
      • Mellanie True Hills
      • Omar KreidiehMD
      • Paul Zei
    • Moderator
      • Edward SchlossMD
      • Janet HanMD, FACC, FHRS